Literature DB >> 18160185

Attachment of the outer membrane lipoprotein (OprI) of Pseudomonas aeruginosa to the mucosal surfaces of the respiratory and digestive tract of chickens.

Karolien Loots1, Hilde Revets, Bruno Maria Goddeeris.   

Abstract

The development of mucosal vaccines requires antigen delivery and adjuvant systems that can efficiently help in presenting vaccine antigens to the mucosal immune system. The outer membrane lipoprotein I (OprI) of Pseudomonas aeruginosa seems to possess both the quality to induce a non-specific immune response (adjuvant effect through its lipid tail) as well as the quality to facilitate uptake of the vaccine antigen by interacting with Toll-like receptor 2/4 (TLR2/4) on antigen-presenting cells (APC) and epithelial cells (adhesion effect). Here, we show for the first time the adhesion of OprI to epithelial cells of the trachea and small intestine of chickens. Adhesion could be seen on cryosections after in vitro as well as after in vivo incubation of the trachea and intestine. This proves the value of OprI as a fusion partner in mucosal protein vaccine development, which is especially important for poultry where mass vaccination is only possible by the respiratory or oral route.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160185     DOI: 10.1016/j.vaccine.2007.11.030

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

2.  Mechanisms of airway responses to esophageal acidification in cats.

Authors:  Ivan M Lang; Steven T Haworth; Bidyut K Medda; Hubert Forster; Reza Shaker
Journal:  J Appl Physiol (1985)       Date:  2016-02-04

Review 3.  Enhancing Protective Efficacy of Poultry Vaccines through Targeted Delivery of Antigens to Antigen-Presenting Cells.

Authors:  Angita Shrestha; Jean-Remy Sadeyen; Munir Iqbal
Journal:  Vaccines (Basel)       Date:  2018-11-15

Review 4.  Immunization and Immunotherapy Approaches against Pseudomonas aeruginosa and Burkholderia cepacia Complex Infections.

Authors:  Sílvia A Sousa; António M M Seixas; Joana M M Marques; Jorge H Leitão
Journal:  Vaccines (Basel)       Date:  2021-06-18

Review 5.  Targeting TLR2 for vaccine development.

Authors:  Afonso P Basto; Alexandre Leitão
Journal:  J Immunol Res       Date:  2014-06-26       Impact factor: 4.818

6.  Pseudomonas aeruginosa cells attached to a surface display a typical proteome early as 20 minutes of incubation.

Authors:  Marc Crouzet; Stéphane Claverol; Anne-Marie Lomenech; Caroline Le Sénéchal; Patricia Costaglioli; Christophe Barthe; Bertrand Garbay; Marc Bonneu; Sébastien Vilain
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.